| Style | Citing Format |
|---|---|
| MLA | Shamabadi A, Akhondzadeh S. "Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction Due to Attenuated Pathogenicity and Booster Vaccine Doses." Avicenna Journal of Medical Biotechnology, vol. 14, no. 2, 2022, pp. 102-103. |
| APA | Shamabadi A, Akhondzadeh S (2022). Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction Due to Attenuated Pathogenicity and Booster Vaccine Doses. Avicenna Journal of Medical Biotechnology, 14(2), 102-103. |
| Chicago | Shamabadi A, Akhondzadeh S. "Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction Due to Attenuated Pathogenicity and Booster Vaccine Doses." Avicenna Journal of Medical Biotechnology 14, no. 2 (2022): 102-103. |
| Harvard | Shamabadi A, Akhondzadeh S (2022) 'Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction Due to Attenuated Pathogenicity and Booster Vaccine Doses', Avicenna Journal of Medical Biotechnology, 14(2), pp. 102-103. |
| Vancouver | Shamabadi A, Akhondzadeh S. Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction Due to Attenuated Pathogenicity and Booster Vaccine Doses. Avicenna Journal of Medical Biotechnology. 2022;14(2):102-103. |
| BibTex | @article{ author = {Shamabadi A and Akhondzadeh S}, title = {Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction Due to Attenuated Pathogenicity and Booster Vaccine Doses}, journal = {Avicenna Journal of Medical Biotechnology}, volume = {14}, number = {2}, pages = {102-103}, year = {2022} } |
| RIS | TY - JOUR AU - Shamabadi A AU - Akhondzadeh S TI - Coronavirus Vaccination and Mortality in the Omicron Outbreak in Iran: Mortality Reduction Due to Attenuated Pathogenicity and Booster Vaccine Doses JO - Avicenna Journal of Medical Biotechnology VL - 14 IS - 2 SP - 102 EP - 103 PY - 2022 ER - |